Bayer CropScience Ltd shares transferred: Bayer AG acquires 5.35 million shares

What Bayer CropScience Ltd announced

Bayer CropScience Ltd filed a disclosure with BSE on 10 July 2026 under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing informs the market that Bayer AG, a promoter of the target company, has acquired 53,54,030 equity shares from Bayer CropScience AG through an inter‑se transfer executed as a block deal on 8 July 2026. The transfer raises Bayer AG’s stake in Bayer CropScience Ltd to 20.34 % of the total diluted share capital.

"This is to inform you that Bayer AG, a promoter of the Target Company has acquired 53,54,030 equity shares from Bayer CropScience AG, another promoter of the Target Company, pursuant to the block deal mechanism on July 8, 2026." – Disclosure letter, 9 July 2026

Details of the inter‑se transfer

• Acquirer: Bayer AG (promoter).
• Persons Acting in Concert (PAC): Bayer CropScience AG, Bayer SAS, Monsanto Company, Bayer Vapi Private Limited, Bayer Investments India Private Limited.
• Target: Bayer CropScience Ltd (BSE code 506285).
• Shares transferred: 53,54,030 equity shares, each with a face value of INR 1.
• Pre‑transaction holding: 37,88,433 shares (8.43 % of total voting capital).
• Post‑transaction holding: 91,42,463 shares (20.34 % of total voting capital).
• Total diluted share capital of the target: 4,49,42,092 shares both before and after the transaction, indicating no change in the overall capital structure.

The acquisition was carried out under the block‑deal mechanism, which allows large share transactions to be executed off‑exchange with a single price point, subject to SEBI reporting requirements.

Regulatory filing under SEBI Regulation 29(2)

Regulation 29(2) mandates that any promoter or person acting in concert who acquires or disposes of shares exceeding 1 % of the voting capital must disclose the transaction to the stock exchange within two business days. The filing includes a detailed breakdown of the acquirer’s holdings before and after the transaction, the mode of acquisition (inter‑se transfer), and the identities of all PACs involved.

The disclosure also confirms that the acquisition does not involve any encumbrance, voting rights other than shares, or convertible securities, simplifying the regulatory assessment. The filing was submitted to BSE on 10 July 2026 and copies were sent to the company’s registered office in Thane, Maharashtra.

Key facts at a glance

Why this matters for investors

The increase in promoter shareholding to 20.34 % strengthens Bayer AG’s voting power in Bayer CropScience Ltd, potentially influencing strategic decisions, board composition, and future capital allocation. Because the transaction is an inter‑se transfer between promoters, it does not dilute existing shareholders – the total number of shares outstanding remains unchanged. However, the shift in share ownership may affect the perception of control dynamics within the company, especially for minority shareholders monitoring promoter influence.

From a regulatory standpoint, the filing satisfies SEBI’s disclosure obligations, ensuring transparency for the market. No new securities were issued, and there is no change to the company’s capital structure, meaning there is no immediate impact on earnings per share or dividend entitlement.

Conclusion

Bayer AG’s acquisition of 53.54 lakh shares from Bayer CropScience AG, disclosed on 10 July 2026, raises its stake in Bayer CropScience Ltd to just over 20 % without altering the company’s total share count. The transaction complies with SEBI Regulation 29(2) and reflects a consolidation of promoter holdings. While the move does not dilute existing shareholders, it does enhance the promoter’s voting strength, a factor investors may monitor in future governance or strategic decisions.